Loyola Medicine acquires MacNeal Hospital, Tenet leaves Chicago

By Catherine Sturman
Tenet Healthcare has sold Chicago located MacNeal hospital to Loyola Medicine for an undisclosed sum, in addition to all affiliated operations which inc...

Tenet Healthcare has sold Chicago located MacNeal hospital to Loyola Medicine for an undisclosed sum, in addition to all affiliated operations which include local Tenet-owned physician practices; the Chicago Health System (“CHS”), an independent practice association of nearly 1,000 physicians; and the associated CHS accountable care organisation.

The acquisition will see MacNeal hospital operate under Loyola, which is sat under the Trinity Health Umbrella.

"Bringing MacNeal into the Loyola system allows us to expand our delivery system, add more providers and deliver exceptional care to a greater number of residents close to their homes," Larry Goldberg, Loyola President and CEO has said.

Related stories

The move will also see Tenet exit what has become a competitive market in Chicago upon completion of the sale in 2018. The company is also looking to also sell its three other Chicago based hospitals through its extensive restructure process, as well eight US hospitals and a number of UK based hospitals in order to streamline its operations.

With growing financial pressures hitting every area of the healthcare industry, Tenet is looking at ways to boost productivity and accumulate further revenue, in order to attract further growth and ensure the delivery of co-ordinated, quality care across the board.

Share

Featured Articles

Philip Morris International (PMI) in agreement with KT&G

PMI and KT&G are building a smoke-free world. In a new agreement between the two companies, smoke-free alternatives are within reach for smokers

Health tech leader Philips shares sustainability ambition

Roy Jakobs, Royal Philips CEO, says the health technology company’s sustainability impact plan will ‘enhance accountability & strengthen talent’

Automating gene therapy & pharma discovery at Automata

Sonia Jassi, Drug Discovery & Synthetic Biology Lead at Automata, explains how automation increases efficiency in gene therapy laboratories

Itai Hayut, CEO of Scopio Labs, on AI & blood cancer

Technology & AI

2023 predictions with Harshit Jain, global CEO of Doceree

Telehealth & COVID-19

Wolters Kluwer Health: health equity and telehealth

Telehealth & COVID-19